Towa Pharmaceutical Co., Ltd. (TYO:4553)

Market Cap	131.88B
Revenue (ttm)	253.35B
Net Income (ttm)	19.28B
Shares Out	49.23M
EPS (ttm)	391.67
PE Ratio	6.84
Forward PE	8.37
Dividend	80.00 (2.92%)
Ex-Dividend Date	Mar 28, 2025

Volume	59,400
Average Volume	147,340
Open	2,720.00
Previous Close	2,743.00
Day's Range	2,674.00 - 2,729.00
52-Week Range	2,488.00 - 3,395.00
Beta	-0.25
RSI	33.26
Earnings Date	May 15, 2025

About Towa Pharmaceutical

Towa Pharmaceutical Co., Ltd., together with its subsidiaries, researches, develops, produces, and sells ethical drugs, active pharmaceutical ingredients, and intermediates in Japan. The company provides its products in the therapeutic areas of digestive system, nervous system, and allergic diseases, as well as vitamins, antibiotics, and oncology products. It also offers IT service related to healthcare; and disease risk testing services. In addition, the company is involved with research and development of diagnostic drugs; and planning, devel...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1951
• Employees: 4,588
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 4553

Financial Performance

In 2023, Towa Pharmaceutical's revenue was 227.93 billion, an increase of 9.13% compared to the previous year's 208.86 billion. Earnings were 16.17 billion, an increase of 634.80%.